Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. (avab uue akna)

Brady KM, Easley RB, Tobias JD.

Allikas‎: Paediatr Anaesth 2006;16(10):1042-6.

Indekseeritud‎: PubMed 16972833

DOI‎: 10.1111/j.1460-9592.2006.02039.x

https://www.ncbi.nlm.nih.gov/pubmed/16972833 (avab uue akna)

The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. (avab uue akna)

Cetin H, Yalaz M, Akisu M, Karapinar DY, Kavakli K, Kultursay N.

Allikas‎: Blood Coagul Fibrinolysis 2006;17(3):213-6.

Indekseeritud‎: PubMed 16575260

DOI‎: 10.1097/01.mbc.0000220245.20036.2d

https://www.ncbi.nlm.nih.gov/pubmed/16575260 (avab uue akna)

The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy. (avab uue akna)

Chuansumrit A, Nuntnarumit P, Okascharoen C, Teeraratkul S, Suwansingh S, Supapannachart S.

Allikas‎: Pediatrics 2002;110(1 Pt 1):169-71.

Indekseeritud‎: PubMed 12093965

https://www.ncbi.nlm.nih.gov/pubmed/12093965 (avab uue akna)

Recombinant activated factor VIIa (rFVIIa) treatment in very-low-birth-weight (VLBW) premature infants with acute pulmonary hemorrhage: a single-center, retrospective study. (avab uue akna)

Cosar H, Isik H, Cakır SC, Yar N, Goksen B, Tokbay H, Kertmen H, Erdoğan N, Durak I.

Allikas‎: Paediatr Drugs 2017;19(1):53-8.

Indekseeritud‎: PubMed 27826851

DOI‎: 10.1007/s40272-016-0203-3

https://www.ncbi.nlm.nih.gov/pubmed/27826851 (avab uue akna)

Recombinant activated factor VIIa treatment for refractory hemorrhage in infants. (avab uue akna)

Dang CN, Katakam LI, Smith PB, Cotten CM, Goldberg RN, Chandler N, Thornburg CD, Bidegain M.

Allikas‎: J Perinatol 2011;31(3):188-92.

Indekseeritud‎: PubMed 20671714

DOI‎: 10.1038/jp.2010.85

https://www.ncbi.nlm.nih.gov/pubmed/20671714 (avab uue akna)

Use of recombinant factor VIIa in infants with severe coagulopathy. (avab uue akna)

Fontaine MJ, Lazarchick J, Taylor S, Annibale D.

Allikas‎: J Perinatol 2004;24(5):310-1.

Indekseeritud‎: PubMed 15116125

DOI‎: 10.1038/sj.jp.7211086

https://www.ncbi.nlm.nih.gov/pubmed/15116125 (avab uue akna)

Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances. (avab uue akna)

Gkiougki E, Mitsiakos G, Chatziioannidis E, Papadakis E, Nikolaidis N.

Allikas‎: J Pediatr Hematol Oncol 2013;35(3):221-6.

Indekseeritud‎: PubMed 23511491

DOI‎: 10.1097/MPH.0b013e318286d27e

https://www.ncbi.nlm.nih.gov/pubmed/23511491 (avab uue akna)

Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage. (avab uue akna)

Grizelj R, Vuković J, Filipović-Grčić B, Šarić D, Luetić T.

Allikas‎: Blood Coagul Fibrinolysis 2006;17(5):413-5.

Indekseeritud‎: PubMed 16788319

DOI‎: 10.1097/01.mbc.0000233373.71970.6f

https://www.ncbi.nlm.nih.gov/pubmed/16788319 (avab uue akna)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (avab uue akna)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Allikas‎: Paediatr Anaesth 2009;19(4):364-70.

Indekseeritud‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (avab uue akna)

The use of recombinant factor VIIa for severe intractable bleeding during spine surgery. (avab uue akna)

Kaw LL Jr, Coimbra R, Potenza BM, Garfin SR, Hoyt DB.

Allikas‎: Spine 2004;29(12):1384-7.

Indekseeritud‎: PubMed 15187645

https://www.ncbi.nlm.nih.gov/pubmed/15187645 (avab uue akna)

Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases. (avab uue akna)

Mitsiakos G, Papaioannou G, Giougi E, Karagianni P, Garipidou V, Nikolaidis N.

Allikas‎: J Pediatr Hematol Oncol 2007;29(3):145-50.

Indekseeritud‎: PubMed 17356391

DOI‎: 10.1097/MPH.0b013e3180335bcb

https://www.ncbi.nlm.nih.gov/pubmed/17356391 (avab uue akna)

Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants. (avab uue akna)

Olomu N, Kulkarni R, Manco-Johnson M.

Allikas‎: J Perinatol 2002;22(8):672-4.

Indekseeritud‎: PubMed 12478454

DOI‎: 10.1038/sj.jp.7210787

https://www.ncbi.nlm.nih.gov/pubmed/12478454 (avab uue akna)

Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. (avab uue akna)

Puetz J, Darling G, Brabec P, Blatny J, Mathew P.

Allikas‎: Pediatr Blood Cancer 2009;53(6):1074-8.

Indekseeritud‎: PubMed 19621430

DOI‎: 10.1002/pbc.22160

https://www.ncbi.nlm.nih.gov/pubmed/19621430 (avab uue akna)